Insights, News & Trends

Here is some valuable information about marketing trends, strategies, and tactics, along with industry news and events as well as all things Vizual.

No. Va. Branding Firm Has Messaging Rx For Pharma Client

April 24 / 2007

Herndon, Virginia, April 24, 2007 – One of the nation’s most dynamic pharmaceutical companies has hired Vizual, a branding and strategic communications firm, to improve its presence on the World Wide Web. Avalon Pharmaceuticals, headquartered in Germantown, MD, is a leader in the development of highly effective cancer-fighting drugs.

One of the keys to Avalon’s new website is a more streamlined site structure with easier navigation for potential partners, clients and investors. According to Jeff Lupisella, principal at Vizual, “We’re excited about this project because it gives us a chance to use a wide range of our areas of expertise. We’re helping Avalon work through some of the more subtle and strategic aspects of their communication, supporting and extending their existing visual brand and also developing a custom database and content management system to allow staff to easily update the site via a browser-based interface.”

The client has already established itself in the marketplace with its AvalonRx® Drug Discovery Engine. The new website that Vizual is creating will allow the client to better communicate with third-party investors and others about the groundbreaking progress the company is making with new oncology drugs in its portfolio.

For ways to improve your organization’s image and marketability, contact Samantha Lentz, Director of Business Development, or Jeff Lupisella, Principal, at 703.437.8018. Or, please visit our website at vizual.com/ and sign up for our quarterly e-newsletter, Glimpse.

About Avalon Pharmaceuticals

Established in 1999, Avalon Pharmaceuticals (avalonrx.com) is a biopharmaceutical company focused on the discovery, development and commercialization of first-in-class cancer therapeutics. The company’s leading product candidate, an IMPDH inhibitor, is in Phase II clinical development, while several other products are in preclinical stages. Avalon’s progressive business model allows it to benefit from partnerships with larger pharmas such as Merck, MedImmune, Medarex and Novartis.

About Vizual

Vizual, Inc. is an integrated marketing services firm that specializes in branding. Since 1994, Vizual has established an outstanding reputation for providing award-winning services, results-oriented strategic consultation, and exceptional client service. To find out more about how Vizual may be able to help your organization, visit vizual.com or call 703-437-8018.

Media Contact: Jeffrey A. Lupisella, 703-437-8018

How can we help?

Ready to take your brand to new heights? Contact us today and we'll create unique solutions that will captivate your audience and drive unparalleled success for your organization.